DELL:NYSEDell Technologies Inc. Analysis
Data as of 2026-06-13 - not real-time
$395.57
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Dell Technologies is riding a wave of extraordinary revenue growth, reporting an 87.5% year‑over‑year increase to $43.84 billion and guiding the next quarter to $44.5 billion—well above consensus. The stock trades at $395.57, comfortably above its DCF fair value of $272.44, delivering a calculated upside of roughly 22% while its forward P/E of 18.7 is materially lower than the industry average of 36.8, suggesting a valuation discount. Technicals remain bullish with the price sitting above the 20‑day (≈$346), 50‑day (≈$264) and 200‑day (≈$168) moving averages, though the MACD histogram has turned negative and the RSI sits at 64, hinting at short‑term overbought conditions. Liquidity is solid—volume is stable and the dividend yield of 0.64% is supported by a low payout ratio of 17.6% and strong operating cash flow. Risk factors are pronounced, as 30‑day volatility exceeds 115% and beta approaches 2, reflecting heightened sensitivity to market swings. The company’s strategic AI‑focused PC launch and deepening Nvidia partnership position it well for continued growth, while its diversified global footprint spreads geographic exposure. Analyst consensus remains a “Buy” with a median price target near $500, underscoring confidence in the upside potential despite the elevated risk profile.
Overall, Dell presents a compelling blend of growth catalysts and a relatively attractive valuation, tempered by high volatility and market‑wide tech sector sensitivities. Investors should weigh the strong earnings momentum and AI opportunities against the heightened beta and near‑term technical softness when timing entry or exit points.
Overall, Dell presents a compelling blend of growth catalysts and a relatively attractive valuation, tempered by high volatility and market‑wide tech sector sensitivities. Investors should weigh the strong earnings momentum and AI opportunities against the heightened beta and near‑term technical softness when timing entry or exit points.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above all major SMAs indicating bullish trend
- Negative MACD histogram and RSI near overbought levels
- Elevated short‑term volatility and beta
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust 87.5% YoY revenue growth and strong guidance
- Forward P/E discount to industry and 22% upside to fair value
- AI‑centric product launch and supportive analyst sentiment
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic shift toward AI and enterprise infrastructure
- Sustainable dividend backed by low payout ratio and cash flow
- Long‑term cash position and manageable debt profile
Key Metrics & Analysis
Financial Health
Revenue Growth87.50%
Profit Margin6.28%
P/E Ratio31.5
ROA7.00%
P/B Ratio-182.9
Op. Cash Flow$12.5B
Free Cash Flow$5.4B
Industry P/E36.8
Technical Analysis
TrendBullish
RSI64.5
Support$227.27
Resistance$469.47
MA 20$346.64
MA 50$263.71
MA 200$167.95
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value$272.44
Target Price$483.83
Upside/Downside22.31%
GradeFair
TypeGrowth
Dividend Yield0.64%
Risk Assessment
Beta1.98
Volatility116.40%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.